Treatment of infected aortic aneurysm or vascular graft infection with a rifampicin-bonded gelatin-sealed Dacron graft

Treatment of infected aortic aneurysm or vascular graft infection with a rifampicin-bonded gelatin-sealed Dacron graft - Usage of rifampicin-bonded gelatin-sealed Dacron graft

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022379

Enrollment

Registered

2016-07-01

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infected aortic aneurysm, vascular graft infection

Interventions

gelatin-sealed Dacron graft is soaked in rifampicin solution before implantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) patients with infectious aortic aneurysm or vascular graft infection diagnosed by imaging study and/or laboratory study (2) patients with refractory to medical treatment

Exclusion criteria

Exclusion criteria: (1) patients with allergic for rifampicin (2) patients who refuse to the study

Design outcomes

Primary

Measure	Time frame
clinical control of infection (imaging study and/or laboratory study)	—

Secondary

Measure	Time frame
patient death	—

Countries

Japan

Contacts

Public ContactKeiich Kanda

Kyoto Prefectural University of Medicine Cardiovascular Surgery

kei@koto.kpu-m.ac.jp0752515752

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026